Skip to main navigation Skip to search Skip to main content

Fluid biomarkers for the diagnosis of neurodegenerative diseases

  • Hackensack Meridian School of Medicine

Research output: Contribution to journal › Review article › peer-review

34 Scopus citations

Abstract

In this review, we evaluate the role of fluid biomarkers related to neurodegenerative diseases. Such conditions present diagnostic challenges due to phenotypic heterogeneity, longitudinal evolution, overlap between diagnostic entities, and variability in progression. Biomarkers can potentially provide insight into diagnosis, progression, prognostication, and treatment efficacy. This review covers recent advances in fluid biomarkers including beta-amyloid, tau protein, neurofilament light chain, alpha-synuclein and glial fibrillary protein, and briefly touches upon imaging biomarkers. For each biomarker, we discuss the pathophysiological correlates, clinical uses, accuracy, and limitations.

Original languageEnglish
Article number100062
JournalBiomarkers in Neuropsychiatry
Volume8
DOIs
StatePublished - Jun 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Alzheimer's Disease
  • Biomarkers
  • Cerebrospinal Fluid
  • Diagnosis
  • Neurodegenerative Disease
  • Plasma

Fingerprint

Dive into the research topics of 'Fluid biomarkers for the diagnosis of neurodegenerative diseases'. Together they form a unique fingerprint.

Cite this